Fox Run Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,118
Closed -$210K 1138
2025
Q4
$210K Sell
4,118
-13,555
-77% -$693K 0.03% 795
2025
Q3
$981K Buy
+17,673
New +$1.03M 0.15% 216
2025
Q2
Sell
-15,119
Closed -$1.05M 1110
2025
Q1
$1.05M Buy
+15,119
New +$1.25M 0.16% 188
2024
Q4
Sell
-7,762
Closed -$924K 1082
2024
Q3
$924K Buy
+7,762
New +$1.04M 0.21% 154
2023
Q3
Sell
-3,182
Closed -$257K 900
2023
Q2
$257K Buy
+3,182
New +$260K 0.07% 499
2022
Q4
Sell
-5,822
Closed -$290K 809
2022
Q3
$290K Buy
+5,822
New +$312K 0.11% 352
2019
Q1
Sell
-24,994
Closed -$576K 627
2018
Q4
$576K Sell
24,994
-854
-3% -$19K 0.31% 70
2018
Q3
$609K Buy
+25,848
New +$631K 0.27% 109
2018
Q2
Sell
-10,110
Closed -$249K 838
2018
Q1
$249K Buy
+10,110
New +$265K 0.06% 558
2017
Q4
Sell
-16,600
Closed -$400K 814
2017
Q3
$400K Buy
+16,600
New +$375K 0.11% 381
2017
Q2
Sell
-26,200
Closed -$449K 764
2017
Q1
$449K Buy
+26,200
New +$456K 0.18% 222
2016
Q3
Sell
-19,400
Closed -$522K 618
2016
Q2
$522K Buy
+19,400
New +$532K 0.25% 113

Other funds holding NVO

Fox Run Management's NVO Position: Q1 2026 in Review

Fox Run Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,118 shares — an estimated $210K sold.

Fox Run Management first reported a position in NVO in Q2 2016 and held it in 12 quarters. The position peaked at $1.05M in Q1 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Fox Run Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 4,118 Novo Nordisk shares in Q1 2026, an estimated $210K.
  • Fox Run Management first reported a position in Novo Nordisk in Q2 2016 and held it in 12 quarters.
  • Fox Run Management's Novo Nordisk position peaked at $1.05M in Q1 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.